Enclomiphene Citrate
Also known as: Enclomiphene, Enclomiphene citrate
Overview
Enclomiphene citrate is a selective estrogen receptor modulator (SERM) primarily used to treat secondary hypogonadism in men. It is a pharmaceutical compound, not a naturally sourced supplement. Its main function is to elevate testosterone levels by stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. This action helps to restore normal testosterone production in men with secondary hypogonadism. Enclomiphene is often considered as an alternative to testosterone replacement therapy, particularly for men who wish to maintain their fertility. It is administered orally and has been shown in clinical trials to effectively increase testosterone levels while preserving sperm production. Research on enclomiphene is moderately mature, with several clinical trials supporting its use, although more systematic reviews are needed to fully understand its long-term effects.
Benefits
Enclomiphene citrate is primarily used to increase serum testosterone levels in men with secondary hypogonadism. By raising LH and FSH levels, it stimulates the testes to produce more testosterone, which can alleviate symptoms of hypogonadism. Unlike testosterone replacement therapy, enclomiphene maintains sperm counts, making it a beneficial option for men who wish to preserve their fertility. Studies have demonstrated significant increases in testosterone levels, with some showing improvements in sperm density. It is particularly beneficial for overweight or obese men with secondary hypogonadism. Clinical trials have shown that enclomiphene can effectively restore testosterone levels to normal ranges within weeks to months of treatment, offering a viable alternative to traditional testosterone replacement.
How it works
Enclomiphene citrate functions as a selective estrogen receptor modulator (SERM). It binds to estrogen receptors in the hypothalamus, blocking the negative feedback effects of estrogen. This action stimulates the release of gonadotropin-releasing hormone (GnRH), which in turn prompts the pituitary gland to secrete LH and FSH. LH then stimulates the Leydig cells in the testes to produce testosterone, while FSH supports spermatogenesis. By selectively modulating estrogen receptors, enclomiphene increases testosterone production without the suppressive effects on sperm production often seen with direct testosterone administration. This mechanism makes it a valuable option for men seeking to treat hypogonadism while maintaining fertility.
Side effects
Enclomiphene citrate is generally considered safe, with fewer adverse events compared to clomiphene citrate. Common side effects are typically mild and infrequent, though specific common side effects are not well-documented. Uncommon side effects may include changes in estradiol levels, but enclomiphene tends to have a more favorable profile compared to clomiphene in this regard. Rare side effects have limited data available. Potential drug interactions may occur with other hormonal therapies. It is contraindicated in pregnancy and lactation, and caution is advised in patients with certain pre-existing medical conditions. Use in pediatric populations is not recommended due to potential effects on growth and development. Monitoring for changes in hormone levels and potential side effects is recommended during treatment.
Dosage
The minimum effective dose of enclomiphene citrate is typically around 12.5 mg to 25 mg per day. Optimal dosage ranges from 12.5 mg to 50 mg per day, depending on the condition being treated and individual response. Doses above 50 mg are less commonly used. It is usually taken once daily. Oral administration is standard. While specific data on the effect of food intake on absorption is limited, it is generally recommended to take it consistently with or without food. There are no specifically identified required cofactors. It is important to adhere to prescribed dosages and consult with a healthcare provider for personalized recommendations.
FAQs
What is enclomiphene citrate used for?
Enclomiphene citrate is primarily used for treating secondary hypogonadism in men, helping to increase testosterone levels while maintaining sperm production, making it suitable for men wishing to preserve fertility.
How does enclomiphene citrate compare to testosterone replacement therapy?
Unlike testosterone replacement therapy, enclomiphene maintains sperm counts by stimulating the body's own testosterone production, offering a fertility-preserving alternative for men with hypogonadism.
What are the common side effects of enclomiphene citrate?
Enclomiphene citrate is generally considered safe, with fewer adverse events compared to clomiphene citrate. Common side effects are typically mild and infrequent, though specific common side effects are not well-documented.
How quickly does enclomiphene citrate work?
Effects are typically observed within weeks to months of treatment, with increased testosterone levels and potential improvements in symptoms of hypogonadism.
Is enclomiphene citrate a natural supplement?
No, enclomiphene citrate is not a natural supplement but a pharmaceutical compound specifically designed to modulate estrogen receptors and stimulate testosterone production.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5009465/ – This study involved two randomized, double-blind, placebo-controlled phase III trials examining the effects of enclomiphene citrate on serum hormone levels and sperm counts in overweight men with secondary hypogonadism. The results showed that enclomiphene treatment maintained sperm counts and increased testosterone levels to normal ranges, demonstrating its efficacy in treating hypogonadism while preserving fertility.
- https://pubmed.ncbi.nlm.nih.gov/36604313/ – This study suggested that enclomiphene citrate may be an effective and safe alternative to testosterone replacement therapy in obese men, highlighting its potential benefits in maintaining fertility. The findings support the use of enclomiphene as a viable option for men seeking to treat hypogonadism without compromising their reproductive potential.
- https://www.cureus.com/articles/161093-efficacy-of-clomiphene-citrate-versus-enclomiphene-citrate-for-male-infertility-treatment-a-retrospective-study – This retrospective study compared the efficacy of clomiphene citrate versus enclomiphene citrate for male infertility treatment. The study provides insights into the comparative effectiveness of these two compounds in addressing male infertility issues.
- https://tau.amegroups.org/article/view/129106/html – This article provides a comprehensive overview of enclomiphene citrate, covering its mechanism of action, clinical applications, and safety profile. It serves as a valuable resource for understanding the role of enclomiphene in treating male hypogonadism and infertility.
- https://onlinelibrary.wiley.com/doi/10.1111/andr.13146 – This study compared the safety profiles of enclomiphene and clomiphene citrate, finding that enclomiphene had a lower rate of adverse events and favorable changes in estradiol levels. The results suggest that enclomiphene may offer a more favorable safety profile compared to clomiphene for treating hypogonadism.